Suppr超能文献

持续阿片类药物暴露诱导痛觉易化:与阿片类药物抗伤害感受性耐受的关系。

Induction of pain facilitation by sustained opioid exposure: relationship to opioid antinociceptive tolerance.

作者信息

Ossipov Michael H, Lai Josephine, Vanderah Todd W, Porreca Frank

机构信息

Department of Pharmacology, University of Arizona, Tucson 85724, USA.

出版信息

Life Sci. 2003 Jun 27;73(6):783-800. doi: 10.1016/s0024-3205(03)00410-7.

Abstract

Opioid analgesics are frequently used for the long-term management of chronic pain states, including cancer pain. The prolonged use of opioids is associated with a requirement for increasing doses to manage pain at a consistent level, reflecting the phenomenon of analgesic tolerance. It is now becoming clearer that patients receiving long-term opioid therapy can develop unexpected abnormal pain. Such paradoxical opioid-induced pain, as well as tolerance to the antinociceptive actions of opioids, has been reliably measured in animals during the period of continuous opioid delivery. Several recent studies have demonstrated that such pain may be secondary to neuroplastic changes that result, in part, from an activation of descending pain facilitation mechanisms arising from the rostral ventromedial medulla (RVM). One mechanism which may mediate such pain facilitation is through the increased activity of CCK in the RVM. Secondary consequences from descending facilitation may be produced. For example, opioid-induced upregulation of spinal dynorphin levels seem to depend on intact descending pathways from the RVM reflecting spinal neuroplasticity secondary to changes at supraspinal levels. Increased expression of spinal dynorphin reflects a trophic action of sustained opioid exposure which promotes an increased pain state. Spinal dynorphin may promote pain, in part, by enhancing the evoked release of excitatory transmitters from primary afferents. In this regard, opioids also produce trophic actions by increasing CGRP expression in the dorsal root ganglia. Increased pain elicited by opioids is a critical factor in the behavioral manifestation of opioid tolerance as manipulations which block abnormal pain also block antinociceptive tolerance. Manipulations that have blocked enhanced pain and antinociceptive tolerance include reversible and permanent ablation of descending facilitation from the RVM. Thus, opioids elicit systems-level adaptations resulting in pain due to descending facilitation, upregulation of spinal dynorphin and enhanced release of excitatory transmitters from primary afferents. Adaptive changes produced by sustained opioid exposure including trophic effects to enhance pain transmitters suggest the need for careful evaluation of the consequences of long-term opioid administration to patients.

摘要

阿片类镇痛药常用于慢性疼痛状态的长期管理,包括癌痛。长期使用阿片类药物与需要增加剂量以维持稳定的疼痛控制水平有关,这反映了镇痛耐受性现象。现在越来越清楚的是,接受长期阿片类药物治疗的患者可能会出现意想不到的异常疼痛。在持续给予阿片类药物期间,动物身上已可靠地测量到这种矛盾的阿片类药物诱导的疼痛以及对阿片类药物抗伤害感受作用的耐受性。最近的几项研究表明,这种疼痛可能继发于神经可塑性变化,部分原因是延髓头端腹内侧(RVM)产生的下行疼痛易化机制的激活。一种可能介导这种疼痛易化的机制是通过RVM中胆囊收缩素(CCK)活性的增加。下行易化可能会产生继发性后果。例如,阿片类药物诱导的脊髓强啡肽水平上调似乎依赖于来自RVM的完整下行通路,这反映了脊髓神经可塑性继发于脊髓上水平的变化。脊髓强啡肽表达的增加反映了持续阿片类药物暴露的营养作用,这种作用促进了疼痛状态的增加。脊髓强啡肽可能部分通过增强初级传入神经兴奋性递质的诱发释放来促进疼痛。在这方面,阿片类药物还通过增加背根神经节中降钙素基因相关肽(CGRP)的表达产生营养作用。阿片类药物引起的疼痛增加是阿片类药物耐受性行为表现的关键因素,因为阻断异常疼痛的操作也会阻断抗伤害感受耐受性。阻断增强的疼痛和抗伤害感受耐受性的操作包括可逆和永久性损毁来自RVM的下行易化。因此,阿片类药物引发系统水平的适应性变化,导致由于下行易化、脊髓强啡肽上调和初级传入神经兴奋性递质释放增强而产生疼痛。持续阿片类药物暴露产生的适应性变化,包括增强疼痛递质的营养作用,提示需要仔细评估长期给患者使用阿片类药物的后果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验